Related Experiment Video
Updated: Nov 3, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Genetic Variants Associated With Unexplained Sudden Cardiac Death in Adult White and African American Individuals
Liang Guo1,2, Sho Torii1,3, Raquel Fernandez1
1CVPath Institute, Gaithersburg, Maryland.
Insights
Genetic variants in cardiomyopathy and arrhythmia genes are found in nearly 20% of unexplained sudden cardiac death (SCD) cases. This suggests a significant genetic contribution to SCD, warranting further research into inherited cardiac conditions.
Area of Science:
- Cardiovascular Genetics
- Sudden Cardiac Death Research
- Genetic Association Studies
Background:
- Unexplained sudden cardiac death (SCD) lacks a clear cause, prompting investigation into genetic factors.
- Inherited cardiomyopathies (CMs) and arrhythmia syndromes are potential contributors to SCD.
- Systematic examination of genetic variants in White and African American adults with unexplained SCD is lacking.
Purpose of the Study:
- To determine the frequency of pathogenic or likely pathogenic (P/LP) genetic variants in inherited CMs and arrhythmia syndromes among unexplained SCD cases.
- To investigate the association between these genetic variants and unexplained SCD in diverse populations.
Main Methods:
- A genetic association study analyzed DNA from 413 adults who died of unexplained SCD (autopsy registry).
- Sequencing focused on 30 CM genes and 38 arrhythmia genes, identifying P/LP variants.
- Data from 683 individuals (White and African American) were collected between 1995 and 2015.
Main Results:
- Nearly 20% (18.4%) of individuals with unexplained SCD carried P/LP variants for CM or arrhythmia genes.
- Specific P/LP variants were identified for hypertrophic CM (10.9%), dilated CM (2.7%), and long QT syndrome (2.7%).
- No significant differences in clinical characteristics were observed; White and African American patients were equally likely to have P/LP variants.
Conclusions:
- Genetic factors, specifically P/LP variants in CM and arrhythmia genes, likely contribute to a substantial proportion of unexplained SCD.
- Findings highlight the importance of genetic testing in unexplained SCD cases.
- Further research into race-specific genetic variants and CM/arrhythmia gene associations is recommended.
Importance:
Unexplained sudden cardiac death (SCD) describes SCD with no cause identified. Genetic testing helps to diagnose inherited cardiac diseases in unexplained SCD; however, the associations between pathogenic or likely pathogenic (P/LP) variants of inherited cardiomyopathies (CMs) and arrhythmia syndromes and the risk of unexplained SCD in both White and African American adults living the United States has never been systematically examined.
Objective:
To investigate cases of unexplained SCD to determine the frequency of P/LP genetic variants of inherited CMs and arrhythmia syndromes.
Design, Setting, And Participants:
This genetic association study included 683 African American and White adults who died of unexplained SCD and were included in an autopsy registry. Overall, 413 individuals had DNA of acceptable quality for genetic sequencing. Data were collected from January 1995 to December 2015. A total of 30 CM genes and 38 arrhythmia genes were sequenced, and variants in these genes, curated as P/LP, were examined to study their frequency. Data analysis was performed from June 2018 to March 2021.
Main Outcomes And Measures:
The frequency of P/LP variants for CM or arrhythmia in individuals with unexplained SCD.
Results:
The median (interquartile range) age at death of the 413 included individuals was 41 (29-48) years, 259 (62.7%) were men, and 208 (50.4%) were African American adults. A total of 76 patients (18.4%) with unexplained SCD carried variants considered P/LP for CM and arrhythmia genes. In total, 52 patients (12.6%) had 49 P/LP variants for CM, 22 (5.3%) carried 23 P/LP variants for arrhythmia, and 2 (0.5%) had P/LP variants for both CM and arrhythmia. Overall, 41 P/LP variants for hypertrophic CM were found in 45 patients (10.9%), 9 P/LP variants for dilated CM were found in 11 patients (2.7%), and 10 P/LP variants for long QT syndrome were found in 11 patients (2.7%). No significant difference was found in clinical and heart characteristics between individuals with or without P/LP variants. African American and White patients were equally likely to harbor P/LP variants.
Conclusions And Relevance:
In this large genetic association study of community cases of unexplained SCD, nearly 20% of patients carried P/LP variants, suggesting that genetics may contribute to a significant number of cases of unexplained SCD. Our findings regarding both the association of unexplained SCD with CM genes and race-specific genetic variants suggest new avenues of study for this poorly understood entity.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs
Incomplete Dominance
Coronary Artery Disease III: Clinical Manifestations
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

